(PharmaNewsWire.Com, May 26, 2017 ) Market Data Forecast has published a new report Europe Hormone Replacement Therapy Market, according to which the market is estimated at $4.10 billion in 2016 and poised to grow $5.68 billion by 2021 with a CAGR of 6.75% in the forecast period.
Hormone replacement therapy is given to some women whose estrogen and progesterone levels drop drastically due to menopause. Hormone replacement therapy tops up a woman's levels of essential hormones. These are receptors that listens signal by hormones and causes growth in women body. There are adverse effects in hormone replacement therapy like, risk of cervical cancer, breast cancer, and uterine cancer.
Estrogen replacement therapy dominated the market in 2015. Also, increasing number of women reaching the menopausal age is anticipated to drive the demand for hormone replacement treatments over the forecast period.
The report provides a detailed analysis of drivers and constraints that controls growth of the market. Some of the drivers are: • Increasing awareness among the masses regarding post-menopause problems. • Currently unmet demand of medicines and therapies. • Government support in terms of policies and funding.
For better understanding Hormone Replacement Therapy Market is segmented by hormone type and route of administration. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
The Europe hormone replacement therapy market is analyzed on the basis of hormone type into Estrogen Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid replacement therapy and others. Responsible for more than half of the market revenues, the estrogen replacement therapy segment dominates the Europe market. The largest consumers of estrogen replacement therapy are post-menopausal women. Growth hormone therapy is used for children, while thyroid replacement therapies are applied to elderly people. Further, on the basis of route of administration the market is segregated under oral, parenteral, transdermal and other routes. The oral route of administration is regarded as one of the safest and most preferred routes of drug administration.
Geographically, the hormone replacement therapy market is analyzed under countries namely, United Kingdom, France, Germany, Italy and Spain. France provides ample opportunities for hormone replacement therapy industry and with more than 50% of the women with menopause symptoms are reported to take hormone replacement therapy.
Some of the key players of hormone replacement industry operating in the European Region are Pfizer, Mylan Laboratories, Novartis, Merck & Co., Bayer, Amgen, Eli Lily, Novo Nordisk, F. Hoffmann-La Roche, Abbott Laboratories, Wyeth and Hisamitsu Pharmaceutical Co. Inc. Recently , Pfizer got extended approval for IBRANCE in HR+2, a drug used for breast therapy.
The Europe Hormone Replacement Therapy Market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of European region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of hormone type and route of administration along with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market.
About us Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
